Hoosier Sport: Refining and Implementing a Sustainable Campus-Community Partnership in Rural Indiana
NCT06602596, Not applicable, Completed, Indiana University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Hoosier Sport: Refining and Implementing a Sustainable Campus-Community Partnership in Rural Indiana | ClinicalTrials.gov |
| NCT number | NCT06602596 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 80 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Indiana University | ClinicalTrials.gov |
| Conditions | CVD, Cardiovascular Diseases | ClinicalTrials.gov |
| Interventions | Hoosier Sport | ClinicalTrials.gov |
| First posted | 2024-09-19 | ClinicalTrials.gov |
| Last updated | 2025-07-11 | ClinicalTrials.gov |
Registered outcomes 15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Feasibility of Intervention Measure (FIM) | Measured at week 0 and week 9 | How feasible the intervention was from the perspective of the participants. This is measured through questionnaire. | ClinicalTrials.gov |
| Primary | Acceptability of Intervention Measure (IAM) | Measured at week 0 and week 9 | How acceptable the intervention is to the participants. This is measured through questionnaire. | ClinicalTrials.gov |
| Primary | Intervention Appropriateness Measure (AIM) | Measured at week 0 and week 9 | How appropriate the intervention is to the participants. This is measured through questionnaire. | ClinicalTrials.gov |
| Secondary | Daily Total Physical Activity of Participants | Week 1 (for 7 days), and week 9 (for 7 days) | Accelerometers (Axivity - AX3 model) will be used to track daily total physical activity | ClinicalTrials.gov |
| Secondary | Heart Rate of Participants | HR will be taken at week 0 and week 9 before and following the 6-minute walk test. | heart rate measured via a blood pressure monitor | ClinicalTrials.gov |
| Secondary | Blood Pressure of Participants | BP will be taken at week 0 and week 9 before and following the 6-minute walk test. | Blood pressure measured via a blood pressure monitor | ClinicalTrials.gov |
| Secondary | Basic Psychological Needs of Participants in Intervention Environment | Assessed at week 0 and week 9 | Basic Psychological Needs and Satisfaction and Frustration scale (BPNSF). This entails feelings/perceptions of autonomy, relatedness, competence, enjoyment, satisfaction, and frustration in the study setting. | ClinicalTrials.gov |
| Secondary | Physical Literacy of Participants | Assessed at week 0 and week 9 | the Canadian Assessment of Physical Literacy second addition (CAPL-2) will be used. A higher score on the CAPL-2 indicates higher physical literacy. | ClinicalTrials.gov |
| Secondary | Cardiovascular Fitness Levels of Participants | Assessed at week 0 and week 9 | the 6-minute walk test will be used to assess changes in fitness. Greater distance walked in the 6 minute time frame is related to greater levels of cardiovascular fitness. | ClinicalTrials.gov |
| Secondary | Muscular Endurance Levels of Participants | Assessed at week 0 and week 9 | The plank test will be used to assess changes in fitness. The longer the plank is held, the greater the muscular endurance of the participant. | ClinicalTrials.gov |
| Secondary | Policy, Systems, and Environmental Factors Influencing Participant Physical Activity and Nutrition Behavior. | Assessed at week 0 and week 9 | a survey will collect data on Policy, Systems and Environmental (PSE) changes using a 5 questions guided by the SNAP-Ed curriculum. Higher scores will indicate better PSE support for physical activity and healthy nutrition opportunities for the participants in their school environment. | ClinicalTrials.gov |
| Other | Daily screen time | Assessed at week 0 and week 9 | data from participants' phone settings will be used to capture daily screen time. Participants will navigate to their screen time settings, where a comprehensive and objective report of their weekly screen time (including average daily screen time) is available. Here, participants will screenshot this data and airdrop it to a secured IU dropbox location. | ClinicalTrials.gov |
| Other | Daily social media usage | Assessed at week 0 and week 9 | data from participants' phone settings will be used to capture daily screen time. Participants will navigate to their screen time settings, where a comprehensive and objective report of their weekly screen time (including average daily social media usage) is available. Here, participants will screenshot this data and airdrop it to a secured IU dropbox location. | ClinicalTrials.gov |
| Other | Social media addiction | Assessed at week 0 and week 9 | participants will complete the Bergen Social Media Addiction Scale to assess social media addiction. | ClinicalTrials.gov |
| Other | Inhibitory control | Assessed at week 0 and week 9 | The Color-Word trial from the Stroop Color and Word Test will be delivered on an iPad/tablet to participants to measure inhibitory control. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 41484781 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Other outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)